Gosuranemab, CAS 1788032-39-2

Product Description: Gosuranemab (BMS-986168) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab binds to human N-terminal tau residues 15-22. Gosuranemab has the potential for the research of alzheimer’s disease (AD)[1][2].

Applications: Neuroscience-Neurodegeneration

Formula: N/A

References: [1]Imbimbo BP, et al. A critical appraisal of tau-targeting therapies for primary and secondary tauopathies. Alzheimers Dement. 2022 May;18(5):1008-1037./[2]Song C, et al. Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond. Transl Neurodegener. 2022 Mar 18;11(1):18.

CAS Number: 1788032-39-2

Molecular Weight: N/A

Compound Purity: 97.31

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: Tau Protein

• Artikelnummer: MEXHY-P99648-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99648-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated